Author

Aldis Pukitis

EVALUATION OF CLINICAL RELATIONSHIP BETWEEN FECAL CALPROTECTIN AND ENDOSCOPIC FINDINGS IN ULCERATIVE COLITIS PATIENTS TREATED WITH INFLIXIMAB (CT-P13) SUBCUTANEOUS AND INTRAVENOUS THERAPY: RESULTS FROM A MULTICENTER, RANDOMIZED, CONTROLLED PIVOTAL TRIAL
EVALUATION OF CLINICAL RELATIONSHIP BETWEEN FECAL CALPROTECTIN AND ENDOSCOPIC FINDINGS IN ULCERATIVE COLITIS PATIENTS TREATED WITH INFLIXIMAB (CT-P13) SUBCUTANEOUS AND INTRAVENOUS THERAPY: RESULTS FROM A MULTICENTER, RANDOMIZED, CONTROLLED PIVOTAL TRIAL

Aldis Pukitis  et al.

EXPOSURE-RESPONSE RELATIONSHIP OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) IN PATIENTS WITH ACTIVE CROHN'S DISEASE AND ULCERATIVE COLITIS: ANALYSIS FROM A MULTICENTER, RANDOMIZED CONTROLLED PIVOTAL TRIAL
EXPOSURE-RESPONSE RELATIONSHIP OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) IN PATIENTS WITH ACTIVE CROHN'S DISEASE AND ULCERATIVE COLITIS: ANALYSIS FROM A MULTICENTER, RANDOMIZED CONTROLLED PIVOTAL TRIAL

Aldis Pukitis  et al.

GENETIC TESTING OF HLA-DQA1-HLA-DRB1 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
GENETIC TESTING OF HLA-DQA1-HLA-DRB1 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Aldis Pukitis  et al.

PANCREATITIS – MICROBIOME AS PREDICTOR OF SEVERITY (P-MAPS): A PROSPECTIVE INTERNATIONAL MULTICENTRE TRANSLATIONAL STUDY
PANCREATITIS – MICROBIOME AS PREDICTOR OF SEVERITY (P-MAPS): A PROSPECTIVE INTERNATIONAL MULTICENTRE TRANSLATIONAL STUDY

Aldis Pukitis  et al.

Item 1 - 4 / 4
1